BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 4622104)

  • 1. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [BPO-Specific, complement-dependant cell-lysis of differently sensitized sheep red cells: evaluation of haptenic groups and their influence on IgM and IgG-induced lysis (author's transl)].
    Wiedermann G; Stemberger H; Förster O; Müller M
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):173-80. PubMed ID: 134537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.
    Ohanian SH; Borsos T
    J Immunol; 1975 Apr; 114(4):1292-5. PubMed ID: 163862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
    Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
    Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IgM rheumatoid factor in experimental immune vasculitis.
    Floyd M; Tesar JT
    Clin Exp Immunol; 1979 Apr; 36(1):165-74. PubMed ID: 157238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of immunosuppression by cobra venom factor. I. On early IgG and IgM responses to sheep erythrocytes and DNP-protein conjugates.
    Martinelli GP; Matsuda T; Osler AG
    J Immunol; 1978 Nov; 121(5):2043-7. PubMed ID: 81862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic modulation of the cytophilic binding of guinea-pig IgG and IgM antibodies to homologous macrophages.
    Webster RO; Lawrence DA
    Immunology; 1979 Apr; 36(4):659-70. PubMed ID: 86509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    Leddy JP; Simons RL; Douglas RG
    J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the chemical structure and the biological activity of antibodies against the foot-and-mouth disease virus].
    Veleva EB
    Vet Med Nauki; 1977; 14(2):89-94. PubMed ID: 199988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement system in cryoglobulinaemia. Interaction with immunoglobulins and lipoproteins.
    Linscott WD; Kane JP
    Clin Exp Immunol; 1975 Sep; 21(3):510-9. PubMed ID: 173488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the inactivation of IgM and IgG complement fixation sites by acid and base.
    Stollar BD; Stadecker MJ; Morecki S
    J Immunol; 1976 Oct; 117(4):1387-91. PubMed ID: 10334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of peptidoglycans with anti-IgGs and with complement.
    Bokisch VA
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):320-30. PubMed ID: 126565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.
    Goldstein IM; Kaplan HB; Radin A; Frosch M
    J Immunol; 1976 Oct; 117(4):1282-7. PubMed ID: 185296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic relationship between the fourth component of human and guinea pig complement.
    Ohanian SH; Borsos T
    J Immunol; 1975 Jan; 114(1 Pt 1):161-4. PubMed ID: 46239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of slow-reacting substance by guinea pig immunoglobulins.
    Jancar S; Akimura OK; Dias da Silva W
    Am J Pathol; 1976 Dec; 85(3):531-48. PubMed ID: 11696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impairment of the cation transport on Rh-pos. human red cells after incubation with IgG-anti-D (author's transl)].
    Weicker H; Ruberg A; Huster H
    Z Immunitatsforsch Immunobiol; 1977 Dec; 153(5):412-27. PubMed ID: 146346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of chemical modifiers on the antigen-binding capacity of antibodies].
    Veleva EB
    Vet Med Nauki; 1976; 13(10):47-54. PubMed ID: 193237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The low ionic strength reaction of human blood: relationship between the binding of serum immunoglobulin and complement of red blood cells and surface charge of the cells.
    Hsu TC; Steinberg J; LeDoux R; Sawitsky A
    Br J Haematol; 1979 Jul; 42(3):403-15. PubMed ID: 38828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.